Bench-to-bedside review: The gut as an endocrine organ in the critically ill
Open Access
- 1 January 2010
- journal article
- review article
- Published by Springer Nature in Critical Care
- Vol. 14 (5) , 228
Abstract
In health, hormones secreted from the gastrointestinal tract have an important role in regulating gastrointestinal motility, glucose metabolism and immune function. Recent studies in the critically ill have established that the secretion of a number of these hormones is abnormal, which probably contributes to disordered gastrointestinal and metabolic function. Furthermore, manipulation of endogenous secretion, physiological replacement and supra-physiological treatment (pharmacological dosing) of these hormones are likely to be novel therapeutic targets in this group. Fasting ghrelin concentrations are reduced in the early phase of critical illness, and exogenous ghrelin is a potential therapy that could be used to accelerate gastric emptying and/or stimulate appetite. Motilin agonists, such as erythromycin, are effective gastrokinetic drugs in the critically ill. Cholecystokinin and peptide YY concentrations are elevated in both the fasting and postprandial states, and are likely to contribute to slow gastric emptying. Accordingly, there is a rationale for the therapeutic use of their antagonists. So-called incretin therapies (glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide) warrant evaluation in the management of hyperglycaemia in the critically ill. Exogenous glucagon-like peptide-2 (or its analogues) may be a potential therapy because of its intestinotropic properties.Keywords
This publication has 103 references indexed in Scilit:
- The use of exenatide in severely burned pediatric patientsCritical Care, 2010
- Effect of small intestinal glucose load on plasma ghrelin in healthy menAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2008
- The relationship between gastric emptying, plasma cholecystokinin, and peptide YY in critically ill patientsCritical Care, 2007
- Prokinetic Effects of a New Ghrelin Receptor Agonist TZP-101 in a Rat Model of Postoperative IleusDigestive Diseases and Sciences, 2007
- Glucagon-Like Peptide-1 Infusion Improves Left Ventricular Ejection Fraction and Functional Status in Patients With Chronic Heart FailureJournal of Cardiac Failure, 2006
- Effects of Ghrelin Administration on Left Ventricular Function, Exercise Capacity, and Muscle Wasting in Patients With Chronic Heart FailureCirculation, 2004
- GLP-2 stimulates intestinal growth in premature TPN-fed pigs by suppressing proteolysis and apoptosisAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2000
- Effects of erythromycin on gastric emptying, duodeno-caecal transit time, gastric and biliopancreatic secretion during continuous gastric infusion of a liquid diet in healthy volunteers.1995
- Motilin agonist erythromycin increases human lower esophageal sphincter pressure by stimulation of cholinergic nervesDigestive Diseases and Sciences, 1994
- Effect of sepsis or cytokine administration on release of gut peptidesThe American Journal of Surgery, 1992